Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

A woman with severe angioedema improved significantly after treatment with rituximab.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.